Cargando…
Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063620/ https://www.ncbi.nlm.nih.gov/pubmed/35503396 http://dx.doi.org/10.1007/s40120-022-00346-8 |
| _version_ | 1784699200952336384 |
|---|---|
| author | Cross, Anne H. Delgado, Silvia Habek, Mario Davydovskaya, Maria Ward, Brian J. Cree, Bruce A. C. Totolyan, Natalia Pingili, Ratnakar Mancione, Linda Hu, Xixi Sullivan, Roseanne Su, Wendy Zielman, Ronald Gupta, Ayan Das Montalban, Xavier Winthrop, Kevin |
| author_facet | Cross, Anne H. Delgado, Silvia Habek, Mario Davydovskaya, Maria Ward, Brian J. Cree, Bruce A. C. Totolyan, Natalia Pingili, Ratnakar Mancione, Linda Hu, Xixi Sullivan, Roseanne Su, Wendy Zielman, Ronald Gupta, Ayan Das Montalban, Xavier Winthrop, Kevin |
| author_sort | Cross, Anne H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9063620 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-90636202022-05-04 Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab Cross, Anne H. Delgado, Silvia Habek, Mario Davydovskaya, Maria Ward, Brian J. Cree, Bruce A. C. Totolyan, Natalia Pingili, Ratnakar Mancione, Linda Hu, Xixi Sullivan, Roseanne Su, Wendy Zielman, Ronald Gupta, Ayan Das Montalban, Xavier Winthrop, Kevin Neurol Ther Correction Springer Healthcare 2022-05-03 /pmc/articles/PMC9063620/ /pubmed/35503396 http://dx.doi.org/10.1007/s40120-022-00346-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Correction Cross, Anne H. Delgado, Silvia Habek, Mario Davydovskaya, Maria Ward, Brian J. Cree, Bruce A. C. Totolyan, Natalia Pingili, Ratnakar Mancione, Linda Hu, Xixi Sullivan, Roseanne Su, Wendy Zielman, Ronald Gupta, Ayan Das Montalban, Xavier Winthrop, Kevin Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title | Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title_full | Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title_fullStr | Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title_full_unstemmed | Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title_short | Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab |
| title_sort | correction to: covid-19 outcomes and vaccination in people with relapsing multiple sclerosis treated with ofatumumab |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063620/ https://www.ncbi.nlm.nih.gov/pubmed/35503396 http://dx.doi.org/10.1007/s40120-022-00346-8 |
| work_keys_str_mv | AT crossanneh correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT delgadosilvia correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT habekmario correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT davydovskayamaria correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT wardbrianj correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT creebruceac correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT totolyannatalia correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT pingiliratnakar correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT mancionelinda correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT huxixi correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT sullivanroseanne correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT suwendy correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT zielmanronald correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT guptaayandas correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT montalbanxavier correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab AT winthropkevin correctiontocovid19outcomesandvaccinationinpeoplewithrelapsingmultiplesclerosistreatedwithofatumumab |